Bone Implant Market Summary
As per MRFR Analysis, the Bone Implant Market was valued at USD 4.54 Billion in 2023 and is projected to grow from USD 5.65 Billion in 2024 to USD 9.82 Billion by 2032, with a CAGR of 11.67% during the forecast period (2024 - 2032). The market growth is driven by an aging population, increasing orthopedic surgeries, and rising sports-related injuries. However, challenges such as high surgery costs and stringent regulations may hinder growth. The market is segmented by biomaterial, product, application, device, and end-user, with key regions including the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Key Market Trends & Highlights
The Bone Implant Market is witnessing significant growth driven by various factors.
- Market Size in 2023: USD 4.54 Billion.
- Projected Market Size by 2032: USD 9.82 Billion.
- CAGR during 2024-2032: 11.67%.
- Major players are adopting inorganic growth strategies, such as Stryker Corporation's acquisition of Vexim for USD 215 million in 2017.
Market Size & Forecast
2023 Market Size: USD 4.54 Billion
2024 Market Size: USD 5.65 Billion
2032 Market Size: USD 9.82 Billion
CAGR (2024-2032): 11.67%
Largest Regional Market Share in 2024: Americas
Major Players
Depuy Synthes Inc. (Johnson & Johnson), Globus Medical, Inc., NuVasive, Inc., Smith & Nephew plc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Medtronic, plc, The Orthopedic Implant Company, Wright Medical Group N.V.

The rapid growth in aged population, increasing number of orthopedic surgeries, and rising occurrences of sports-related injuries are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by top players such as new product launches are contributing to the growth of the bone implant market. For instance, in May 2018, NN Inc. acquired Paragon Medical for USD 375 million. Paragon Medical is a medical device manufacturer which focuses on orthopedics, case and tray, and implant and instrument markets. The acquisition supports NNs Inc.โs strategy to grow its life science revenue and positions NN Inc. as one of the ten largest contract manufacturers in orthopedics.
The rising cost of orthopedic surgeries, the high price of bone implant products, corrosion and instability of bioimplants, and stringent government policies may hinder the growth of the market during the assessment period.
Bone Implant Market Segment Insights
The bone implant market has been segmented on the basis of biomaterial, product, application, device, and end-user.
On the basis of biomaterial, the market has been classified as metals, ceramics, and polymers. The metal segment has been further divided into titanium, stainless steel, cobalt chromium alloy, gold alloys, and Tantalum. The ceramics segment has been further divided into alumina, hydroxyapatite, beta-tricalcium, phosphate, carbon, bioglass, zirconia, and zirconia-toughened alumina. The polymers segment has been classified into polymethylmethacrylate, polytetrafluoroethylene, polyethylene, polysulfone, polyurethane, and polyether ether ketone.
The market, by products, is divided into orthopedic screws, orthopedic plates, interlocking nails (rods), and others. The market, by application, has been classified into hip orthopedic implants, knee orthopedic implants, spine orthopedic implants, dental orthopedic implants, and others.
The market, by device, is divided into external fixators and internal fixators.
The market, by end-user, has been segmented into orthopedic clinics, hospitals, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The bone implant market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European bone implant market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The bone implant market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas is likely to dominate the bone implant market. The rising occurrence of osteoarthritis and osteoporosis in the aging population, increase in the number of surgical procedures, the presence of a well-established healthcare system, growing prevalence of sports injuries, and adoption of highly advanced technology are contributing to the growth of the market. According to the Annual Report of the American Joint Replacement Registry (AJRR), 860,080 hip and knee replacement procedures from 4,755 surgeons at 654 institutions were conducted in 2017.
The European market is expected to be the second-largest bone implant market. The market growth in this region can be attributed to the rising prevalence of orthopedic diseases. Moreover, the increasing demand for orthopedic implants and spinal treatment devices during the forecast period are contributing to the growth of the market in this region. Major players are adapting inorganic growth policies to expand their portfolio. For instance, Stryker Corporation, a major player in the orthopedic market acquired Vexim for USD 215 million in 2017. Vexim offers spine related products, which helped Stryker Corporation to capture the new segment.
Asia-Pacific is expected to be the fastest-growing bone implant market during the forecast period owing to the increasing prevalence of medical tourism, orthopedic diseases along with bone-related issues, and rising investments in healthcare and expansions by market players in the region. Asia-Pacific is anticipated to show significant growth from 2024 to 2032
The market in the Middle East and Africa is expected to account for the smallest share of the bone implant market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the bone implant market areย
- Depuy Synthes Inc. (Johnson & Johnson),ย
- Zimmer Biomet Holdings, Inc.,ย
- Integra LifeSciences Holdings Corporation,ย
- The Orthopedic Implant Company,ย
- Wright Medical Group N.V.,ย
- Aesculap Implant Systems,ย
- BioTek Instruments, Inc.,ย
- Arthrocare Corporation, and others.
Bone Implant Market Segmentation
Bone Implant Biomaterial Outlook
- Beta-Tricalcium phosphate
- Zirconia-toughened alumina
Bone Implant Product Outlook
- Interlocking Nails (Rods)
Bone Implant Application Outlook
- Spine Orthopedic Implants
- Dental Orthopedic Implants
Bone Implant Device Outlook
Bone Implant End-User Outlook
Bone Implant Regional Outlook
Report Attribute/Metric
|
Details
|
Market Size 2023
|
4.54 (USD Billion)
|
Market Size 2024
|
5.65 (USD Billion)
|
Market Size 2032
|
9.82 (USD Billion)
|
Compound Annual Growth Rate (CAGR)
|
11.67 % (2024 - 2032)
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
Base Year
|
2023
|
Market Forecast Period
|
2024 - 2032
|
Historical Data
|
2019 - 2023
|
Forecast Units |
Value (USD Billion) |
Segments Covered |
Type, Application, and End-User |
Geographies Covered |
North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors |
Depuy Synthes Inc. (Johnson & Johnson), Globus Medical, Inc., NuVasive, Inc., Smith & Nephew plc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Medtronic, plc, The Orthopedic Implant Company, Wright Medical Group N.V., Aesculap Implant Systems, BioTek Instruments, Inc., Conmed Corporation, Arthrocare Corporation, and others. |
Key Market Opportunities |
Increasing government support, rising investments in healthcare, and the presence of a well-established pharmaceutical market |
Key Market Drivers |
The rapid growth in the aged population, increasing number of orthopedic surgeries, rising occurrences of sports-related injuries, increasing applications of bone implants in diagnostics, and rising R&D spending. |
Bone Implant Market Highlights:
Frequently Asked Questions (FAQ) :
Bone Implant Market is projected to grow at an 11.67% CAGR between 2024-2032.
The Americas is expected to lead the Bone Implant Market.
It is widely used as dental orthopedic implants, spine orthopedic implants, hip and knee orthopedic implants, and others.
Increasing prevalence of bone weakness and sports related injuries are boosting market growth.
High surgery and product cost may limit market growth.